• DOI:10.1080/09513590601010508
Corpus ID: 41735428

Metformin reduces abortion in pregnant women with polycystic ovary syndrome

@article{Khattab2006MetforminRA,
  title={Metformin reduces abortion in pregnant women with polycystic ovary syndrome},
  author={S. Khattab and I. A. Mohsen and I. A. Foutouh and A. Ramadan and Mohamed Moaz and H. Al-Inany},
  journal={Gynecological Endocrinology},
  year={2006},
  volume={22},
  pages={680 - 684}
}

S. Khattab, I. A. Mohsen, +3 authors H. Al-Inany

Published 2006

Medicine

Gynecological Endocrinology

Background. Women with polycystic ovary syndrome (PCOS) are considered to be at increased risk of miscarriage. Since metformin has beneficial effects on the risk factors contributing to first-trimester abortion in PCOS patients, we hypothesized that metformin – owing to its metabolic, endocrine, vascular and anti-inflammatory effects – may reduce the incidence of first-trimester abortion in PCOS women. Materials and methods. A prospective cohort study was set up to determine the beneficial… CONTINUE READING

View on Taylor & Francis

ncbi.nlm.nih.gov

Save to Library

Create Alert

Cite

Launch Research Feed